Pediatric patients suffering from ependymoma are usually treated with cranial or craniospinal three-dimensional (3D) conformal radiotherapy (3DCRT). Intensitymodulated techniques spare dose to the surrounding tissue, but the risk for second malignancies may be increased due to the increase in low-dose volume. The aim of this study is to investigate if the flattening filter free (FFF) mode allows reducing the risk for second malignancies compared to the mode with flattening filter (FF) for intensity-modulated techniques and to 3DCRT. A reduction of the risk would be advantageous for treating pediatric ependymoma. 3DCRT was compared to intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) with and without flattening filter. Dose-volume histograms (DVHs) were compared to evaluate the plan quality and used to calculate the excess absolute risk (EAR) to develop second cancer in the brain. Dose verification was performed with a two-dimensional (2D) ionization chamber array and the out-of-field dose was measured with an ionization chamber to determine the EAR in peripheral organs. Delivery times were measured. Both VMAT and IMRT achieved similar plan quality in terms of dose sparing in the OAR and higher PTV coverage as compared to 3DCRT.
| INTRODUCTION
The standard therapy for childhood ependymoma is surgery followed by adjuvant radiation. 1, 2 Historically, cranial or craniospinal irradiation was the standard treatment after surgery 3 in order to assure that the volume adjacent to the target receives adequate dose and consequently assure local control. However, recent publications have
shown that conformal, intensity-modulated (IMRT) and proton-beam radiotherapy can achieve similar local control rates to those published in historical publications without an increased risk of marginal failure. [4] [5] [6] [7] An advantage of IMRT over three-dimensional (3D) conformal standard technique is to spare dose in surrounding normal tissues.
However, a concern about the IMRT treatment is that the volume that receives a low dose can be significantly higher compared to those volumes for conventional technique. This might increase the risk for second malignancies, which is a very important issue with regard to the life expectancy of these pediatric patients. 8 A recent development in the linear accelerator technology is the irradiation without a flattening filter in the beam path to increase dose rate and reduce beam-on time. 9 A reduction of the treatment time would represent an additional advantage, especially in the treatment of pediatric patients. The flattening filter produces scatter radiation; therefore, its removal has the positive effect of reducing the out-of-field dose, 10 which may lead to reduced second cancer risk as it has been shown for the treatment of breast cancer in a previous study. 11 To our knowledge, no reports about second cancer risk have been published for ependymoma. The excess absolute risk (EAR) of developing a second cancer after exposure to radiation (EAR) can be estimated from dose-volume histograms (DVHs) based on biological models which are fitted to data of atomic bomb survivors and Hodgkin patients treated with radiation therapy. 12, 13 The purpose of our study was therefore to investigate whether the flattening filter free mode (FFF) is advantageous with respect to the second cancer risk, plan quality, and delivery time after radiation therapy of ependymoma as compared with the flat beam mode (FF).
| MATERIALS AND METHODS

2.A | Patients and treatment planning
Computed tomography (CT) data of 11 pediatric patients with ependymoma were selected from our treatment database for a retrospective planning study. The age of the patients ranged from 22 months to 15 yr with a mean of 6.5 yr and a median of 4.6 yr. All patients were completely resected and without metastases. The irradiation approach was used in this planning study in the same way as in the HIT Interim (bottom) and a 9.7 cm (top) stack of RVW slabs (PTW, Freiburg, Germany). AAPM TG119 recommendations were used for the dose verification acceptance. 16, 17 Gamma indices 18 were calculated with a dose tolerance of 3% of the maximum dose and 3 mm distance to agreement and the gamma criterion was considered fulfilled if γ < 1 in at least 95% of the pixels.
In the low-dose region, the EAR presents a linear dose-response. 19, 20 Since planning CT data do not include images at larger Simultaneously, total delivery times were measured from first beam on to last beam off.
2.C | Excess absolute risk calculation and organ equivalent dose
The excess absolute risk (EAR) to develop a solid cancer describes the absolute difference in cancer rates of persons exposed to a dose d and those not exposed to a dose beyond the natural dose exposition per 10,000 person-year and is described as lðe; aÞ ¼ expðc e ða-30Þ þ c a lnða=70ÞÞ
For this study, the EAR values are calculated for gender-averaged persons at an age at exposure of 10 yr and an attained age of 70 yr and reported per 10,000 person-years. EAR 0 , γ e , and γ a values have T A B L E 1 DVO used for optimization and tolerance dose for each structure. 
been derived by Preston et al. 20 from the data of the Japanese atomic bomb survivors (EAR 0 = 0.7 per 10,000 person-years per Gy for the brain, γ e = −0.024, and γ a = 2.38). Large errors are involved in the determination of the parameters EAR 0 and μ; therefore, absolute risk results have to be viewed with care.
It is known, that for doses below 2 Gy, the dose-response is linear. 8 For higher doses, the concept of an organ equivalent dose (OED), which is proportional to EAR, has been defined by Schneider et al. 12, 13 :
VðD i ÞREDðD i Þ Therefore, risk ratios for different treatment plans are equivalent to OED ratios which can be determined with the RED function and DVH.
There are different models for the RED calculation, based on different assumptions on the behavior of cells after dose exposition. 23 The linear model assumes a linear response over the whole dose range:
The mechanistic model accounts for cell killing and fractionation effects 23, 24 : Previous studies have demonstrated that for inhomogeneous dose distributions above 4 Gy, the linear-exponential, the plateau, and the full mechanistic model represent a better description of the dose-response function compared to the linear model. 12, 23 Therefore, this model was not included in our results. comparisons, 29 Holm-Bonferroni 30 step-down method for multiple testing was applied to control the maximum experimentwise error rate (MEER). 31 
2.D | Evaluation
| RESULTS
A comparison of dose distributions and DVH for all techniques and modes is shown in Fig. 2 for one typical case. Isodoses are shown for the range of 10-110% of 50.4 Gy. In the sagittal slice, the lowdose region is represented for the range of 1-4% for better comparison of the dose distribution in low-dose region.
Plan quality was evaluated by means of the DVH and dose distributions. Details of relevant DVH parameters are given in Table 2 averaged over all patients. Threshold doses listed in Table 1 Since no plan exceeded the threshold values, all plans achieved acceptable plan quality in terms of dose sparing in the OARs.
3.A | Dosimetry and delivery
Gamma evaluation of the verification of dose calculation is shown in Table 3 . All 44 IMRT and VMAT plans passed the evaluation with passing rates >95% as recommended by the AAPM TG119. 16, 17 On average, IMRT FFF achieved a higher gamma passing rate than the other techniques, but no significant differences were found.
Total delivery times are also listed in Table 3 . Both VMAT modes reduced the delivery time significantly (P = 0.003) by 50% compared to 3DCRT. Both IMRT modes doubled significantly the delivery time compared to 3DCRT (P = 0.003).
Peripheral dose was measured with an ionization chamber in the measurement setup of Fig. 1 ; the measured doses are listed in 
| DISCUSSION
The main objective of this study is to investigate the potential of the FFF mode of a linear accelerator to reduce the radiation-induced second cancer risk, the treatment time, and to improve the treatment plan quality in pediatric ependymoma.
The major concern of using inverse treatment planning for the treatment of ependymoma is that the high-dose falloff at the margin of the PTV might lead to a decrease of the local tumor control.
However, recent publications for ependymoma showed that the local control and overall survival achieved with IMRT are not inferior to those associated with conventional therapy. 4 Pediatric patients are particularly vulnerable to radiation exposure. The peripheral dose in pediatric radiation has been previously investigated by Mansur et al. 35 Their investigation showed that the peripheral dose at large distances using 3DCRT was lower than using therefore, all significant results remained significant after the test.
| CONCLUSION
The results of this study show that VMAT FFF is a technique to consider for treating childhood ependymoma. Compared to the standard technique used for ependymoma, VMAT FFF achieved significantly higher PTV coverage and allowed reducing treatment time significantly. The risk of radiation-induced secondary cancer, which is a major concern in radiation therapy of pediatric patients, was significantly reduced for organs located at large distance from the target, for example, bladder, gonads, or bowel. No advantage could be observed with respect to the secondary cancer risk in the brain.
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